StockData
Sonoma Pharmaceuticals, Inc. logo

Sonoma Pharmaceuticals, Inc. (SNOA) stock

SNOANasdaqSurgical & Medical Instruments & ApparatusFiscal year ends March 31
Financials through Q1 FY2027, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 11/3082% below fair value
$0.83−0.01 (-0.76%)

Close on Nov 18, 2026Market cap $3.96MP/E –Yield –

Sonoma Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Sonoma Pharmaceuticals's market cap was $5.93M on Nov 11, 2026, against $5.49M a year earlier. Over the last 5 years it ranged from $838.08K to $13.70M, with a median of $4.87M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$5.93M-1.2%
2025Dec 31, 2025$6.01M+66.8%
2024Dec 31, 2024$3.60M+285.4%
2023Dec 29, 2023$934.35K-73.1%
2022Dec 30, 2022$3.48M-74.6%
2021Dec 31, 2021$13.70M-7.5%
2020Dec 31, 2020$14.82M+157.9%
2019Dec 31, 2019$5.75M+24.9%
2018Dec 31, 2018$4.60M-80.5%
2017Dec 29, 2017$23.56M+11.2%
2016Dec 30, 2016$21.20M+12.3%
2015Dec 31, 2015$18.88M+53.8%
2014Dec 31, 2014$12.28M-46.8%
2013Dec 31, 2013$23.09M+15.5%
2012Dec 31, 2012$19.99M-29.1%
2011Dec 30, 2011$28.20M–

More Sonoma Pharmaceuticals figures

See a number that looks wrong?